357 related articles for article (PubMed ID: 36038948)
1. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.
Wang X; Chen T; Li C; Li W; Zhou X; Li Y; Luo D; Zhang N; Chen B; Wang L; Zhao W; Fu S; Yang Q
J Hematol Oncol; 2022 Aug; 15(1):122. PubMed ID: 36038948
[TBL] [Abstract][Full Text] [Related]
2. Circular RNAs in the chemoresistance of triple-negative breast cancer: A systematic review.
Wang H; Shan X; Peng Y; Zhou W
Drug Dev Res; 2023 Aug; 84(5):805-814. PubMed ID: 37114737
[TBL] [Abstract][Full Text] [Related]
3. Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway.
Du C; Zhang J; Zhang L; Zhang Y; Wang Y; Li J
J Gene Med; 2021 Sep; 23(9):e3365. PubMed ID: 34031947
[TBL] [Abstract][Full Text] [Related]
4. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
5. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.
Fan Y; Wang J; Jin W; Sun Y; Xu Y; Wang Y; Liang X; Su D
Mol Cancer; 2021 Feb; 20(1):25. PubMed ID: 33530981
[TBL] [Abstract][Full Text] [Related]
6. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
[TBL] [Abstract][Full Text] [Related]
7. A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast cancer.
Song R; Guo P; Ren X; Zhou L; Li P; Rahman NA; Wołczyński S; Li X; Zhang Y; Liu M; Liu J; Li X
Mol Cancer; 2023 Jul; 22(1):104. PubMed ID: 37408008
[TBL] [Abstract][Full Text] [Related]
8. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.
Yang R; Xing L; Zheng X; Sun Y; Wang X; Chen J
Mol Cancer; 2019 Jan; 18(1):4. PubMed ID: 30621700
[TBL] [Abstract][Full Text] [Related]
9. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.
Wang L; Zhou Y; Jiang L; Lu L; Dai T; Li A; Chen Y; Zhang L
Mol Cancer; 2021 Mar; 20(1):43. PubMed ID: 33648498
[TBL] [Abstract][Full Text] [Related]
10. CircRNA_0044556 diminishes the sensitivity of triple‑negative breast cancer cells to adriamycin by sponging miR‑145 and regulating NRAS.
Chen J; Shi P; Zhang J; Li Y; Ma J; Zhang Y; Liu H
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913063
[TBL] [Abstract][Full Text] [Related]
11. CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple-negative breast cancer by targeting miR-761/DACT2 signaling axis.
Huang S; Xie J; Lei S; Fan P; Zhang C; Huang Z
Mol Carcinog; 2023 Apr; 62(4):450-463. PubMed ID: 36562476
[TBL] [Abstract][Full Text] [Related]
12. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
Zhang J; Xu HD; Xing XJ; Liang ZT; Xia ZH; Zhao Y
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5315-5322. PubMed ID: 31298383
[TBL] [Abstract][Full Text] [Related]
13. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
Tang H; Huang X; Wang J; Yang L; Kong Y; Gao G; Zhang L; Chen ZS; Xie X
Mol Cancer; 2019 Feb; 18(1):23. PubMed ID: 30744636
[TBL] [Abstract][Full Text] [Related]
14. Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review.
Foruzandeh Z; Dorabadi DG; Sadeghi F; Zeinali-Sehrig F; Zaefizadeh M; Rahmati Y; Alivand MR
Mol Biol Rep; 2022 Oct; 49(10):9825-9840. PubMed ID: 35534586
[TBL] [Abstract][Full Text] [Related]
15. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.
He R; Liu P; Xie X; Zhou Y; Liao Q; Xiong W; Li X; Li G; Zeng Z; Tang H
J Exp Clin Cancer Res; 2017 Oct; 36(1):145. PubMed ID: 29037220
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448.
Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H
Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026
[TBL] [Abstract][Full Text] [Related]
17. circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis.
Yu J; Shen W; Xu J; Gong B; Gao B; Zhu J
Technol Cancer Res Treat; 2020; 19():1533033820950827. PubMed ID: 32938310
[TBL] [Abstract][Full Text] [Related]
18. CircSNX25 mediated by SP1 promotes the carcinogenesis and development of triple-negative breast cancer.
Gao H; Tuluhong D; Li X; Zhu Y; Xu C; Wang J; Li H; Wang S; Ding W
Cell Signal; 2023 Sep; 109():110776. PubMed ID: 37331414
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis.
Huang Y; Zheng S; Lin Y; Ke L
Mol Cell Biol; 2021 Sep; 41(10):e0060920. PubMed ID: 34370552
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Circ_0000977-Mediated Regulatory Network in Breast Cancer: A Potential Discriminative Biomarker for Triple-Negative Tumors.
Darbeheshti F; Mansoori Y; Azizi-Tabesh G; Zolfaghari F; Kadkhoda S; Rasti A; Rezaei N; Shakoori A
Biochem Genet; 2023 Aug; 61(4):1487-1508. PubMed ID: 36645554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]